Exhibit 107
Calculation of Filing Fee Table
FORM S-3
(Form Type)
NeuroBo Pharmacetuicals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount to be Registered | Proposed Maximum Offering Price Per Share | Proposed Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee (3) | |||||||||||||||||
| Fees to be paid | Equity | Common stock, $0.0001 par value per share | Other(2) | 22,629,907 | $0.76 | $17,198,729 | 0.0001102 | $1,895.30 | ||||||||||||||||
| Total Offering Amounts | $1,895.30 | |||||||||||||||||||||||
| Total Fee Offsets | $- | |||||||||||||||||||||||
| Net Fee Due | $1,895.30 | |||||||||||||||||||||||
| (1) | Represents shares offered by the selling stockholders consisting of (a) 12,629,907 outstanding shares of the Registrant’s common stock and (b) 10,000,000 shares of the Registrant’s common stock issuable upon the exercise of outstanding warrants to purchase the Registrant’s common stock. Includes an indeterminable number of additional shares of common stock, pursuant to Rule 416 under the Securities Act of 1933, as amended, that may be issued to prevent dilution from stock splits, stock dividends or similar transactions that could affect the shares to be offered by the selling stockholders. |
| (2) | Estimated in accordance with Rules 457(c) and 457(h) solely for the purpose of calculating the registration fee on the basis of $0.76 per share, which represents the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Capital Market on January 18, 2023. |
